Core Viewpoint - The last coverage of General Motors Company highlighted a positive outlook based on inventory analysis, suggesting a "Buy" recommendation [1]. Group 1 - The previous article on General Motors was published on March 4, 2025, emphasizing the importance of inventory data in investment decisions [1]. - The investment style promoted by the company focuses on providing actionable and clear ideas derived from independent research [1]. Group 2 - The company claims to have assisted its members in outperforming the S&P 500 while avoiding significant losses during periods of high volatility in both equity and bond markets [2]. - A trial membership is offered to potential investors to evaluate the effectiveness of the company's investment methods [2].

Financial Results - Dollar General Corporation is set to release its first-quarter financial results on June 3, with expected earnings of $1.49 per share, a decrease from $1.65 per share in the same period last year [1] - The company anticipates quarterly revenue of $10.29 billion, up from $9.91 billion a year earlier [1] - Dollar General has exceeded analyst revenue estimates for two consecutive quarters and five out of the last six quarters [1] Stock Performance - Dollar General shares experienced a slight decline of 0.1%, closing at $97.17 on Monday [2] Analyst Ratings - UBS analyst Michael Lasser maintained a Buy rating and raised the price target from $95 to $120 [9] - Telsey Advisory Group analyst Joseph Feldman maintained a Market Perform rating and increased the price target from $85 to $100 [9] - B of A Securities analyst Robert Ohmes maintained a Buy rating and raised the price target from $100 to $115 [9] - Goldman Sachs analyst Kate McShane maintained a Buy rating and increased the price target from $85 to $96 [9] - Morgan Stanley analyst Simeon Gutman maintained an Equal-Weight rating and raised the price target from $80 to $85 [9]

Core Points - Addex Therapeutics, a clinical-stage biopharmaceutical company, focuses on developing novel small molecule allosteric modulators for neurological disorders [4] - The company's lead drug candidate, dipraglurant, is being evaluated for brain injury recovery, including post-stroke and traumatic brain injury recovery [4] - The 2025 Annual General Meeting (AGM) is scheduled for June 24, 2025, in Geneva, Switzerland [1] Agenda Summary - Approval of the Annual Report and Financial Statements for 2024 [2] - Consultative vote on the Compensation Report for 2024 [3] - Re-elections of Board members, including Vincent Lawton as Chairman [3] - Approval of compensation for Board members and Executive Management [3] - Re-election of Auditors and Independent Voting Rights Representative [3] Company Overview - Addex holds a 20% equity interest in Neurosterix LLC, which is advancing allosteric modulator programs for various neurological conditions [4] - The company is also developing a GABAB PAM drug candidate in partnership with Indivior for substance use disorders [4] - Addex shares are listed on the SIX Swiss Exchange and NASDAQ under the ticker symbol "ADXN" [4]

Core Viewpoint - Dollar General and Dollar Tree are experiencing a rebound in stock prices due to turnaround strategies aimed at improving operational efficiency, with upcoming quarterly results anticipated by investors [1]. Group 1: Turnaround Strategies - Dollar General is implementing a "Back to Basics" strategy focusing on inventory management, store remodels, and reducing shrinkage to enhance operational efficiency and customer satisfaction [2]. - Dollar Tree plans to sell its struggling Family Dollar business to Brigade Capital for $1 billion, which is significantly lower than the original $8 billion purchase price, aiming to alleviate declining profitability and overhead costs [3]. Group 2: Performance Overview - Dollar General stock is currently trading 30% below its 52-week high of $141, while Dollar Tree shares are 25% below their one-year high of $121. Both stocks have rebounded over 20% year to date, with a surge of more than 30% in the last three months [4]. Group 3: Q1 Expectations - Dollar General's Q1 sales are projected to increase by 4% year over year to $10.29 billion, with an expected EPS decline to $1.47 from $1.65 a year ago. However, there is potential for Dollar General to surpass earnings expectations with a more accurate estimate of $1.51 [5]. - Dollar Tree's Q1 sales are expected to drop to $4.54 billion from $7.63 billion in the prior year, with earnings anticipated to decrease by 17% to $1.19 per share. The most accurate estimate suggests a potential EPS of $1.25, which is 5% above the Zacks Consensus [7][8]. Group 4: Valuation Comparison - Both Dollar General and Dollar Tree are trading at 17X forward earnings, which is a discount compared to the S&P 500 and the Zacks Retail-Discount Stores Industry average of 22X. They also trade under the optimal level of less than 2X sales [9]. Group 5: Investment Outlook - Both companies hold a Zacks Rank 3 (Hold) ahead of their Q1 reports, with future upside dependent on demonstrating a turnaround in operational efficiency and meeting or exceeding Q1 expectations [11][12].

Core Viewpoint - Dollar General Corporation is set to release its first-quarter fiscal 2025 earnings results on June 3, which could indicate the effectiveness of its turnaround strategy and influence investor decisions on buying, holding, or selling the stock [1]. Financial Performance - Revenue is expected to increase to $10.29 billion, reflecting a 3.8% year-over-year improvement, while earnings per share (EPS) is projected to decline by 10.9% to $1.47 [2][7]. - The company has a trailing four-quarter negative earnings surprise of 1.2% on average, but it beat the Zacks Consensus Estimate by 12% in the last reported quarter [3]. Earnings Predictions - The Earnings ESP for Dollar General is +2.64%, and it holds a Zacks Rank of 3 (Hold), suggesting a likelihood of an earnings beat [4][5]. - The consensus estimates for future quarters show stability, with EPS projected at $1.56 for the next quarter and $5.58 for the current year [3]. Strategic Initiatives - Dollar General's focus on expanding market share in consumables and non-consumables, along with proactive pricing strategies and private-label offerings, is expected to support revenue growth [6][7]. - Initiatives like DG Fresh, SKU rationalization, and digitization are anticipated to improve same-store sales, projected to increase by 0.8% for the quarter [7][8]. Market Position and Stock Performance - Dollar General shares have increased by 35.3% over the past three months, outperforming the industry average of 0.2% and key competitors [11]. - The stock is currently trading at a forward P/E ratio of 16.84, which is a discount compared to the industry average of 33.73 and the S&P 500's P/E of 21.71 [12]. Valuation Comparison - Dollar General's P/E ratio is higher than Target's (12.03) and Dollar Tree's (16.71) but lower than Costco's (53.65), indicating a mixed valuation landscape [13]. Investment Outlook - While Dollar General shows signs of operational discipline and potential for gradual recovery, near-term margin pressures and earnings challenges suggest that current investors may hold the stock, while potential investors might wait for clearer signs of margin stabilization [16].

Core Insights - Global auto executives are warning of an imminent shortage of rare-earth magnets from China, which are essential for various automotive systems, potentially leading to U.S. car plant shutdowns within weeks [1] Group 1: Supply Chain Disruptions - The head of the Alliance for Automotive Innovation raised concerns in a letter to the Trump administration about the shortage of rare-earth magnets from China, which could disrupt U.S. vehicle production [2][3] - China controls over 90% of global processing for rare-earth magnets and introduced new export rules in April, causing a 50% drop in exports due to complicated permit application processes [5] - U.S. automakers are at risk of production halts due to the shortage, with some Indian car manufacturers potentially facing shutdowns as early as June [8] Group 2: Economic Impact - The rare-earth shortage poses a serious threat to automakers, particularly those relying on just-in-time inventory systems, which could disrupt production schedules and delay vehicle rollouts [9] - The tariff impacts are expected to reduce U.S. auto sales by approximately 500,000 vehicles, negatively affecting automakers' sales and earnings [12] - General Motors has cut its 2025 guidance due to macroeconomic uncertainty, while Ford has suspended its full-year 2025 guidance, warning of potential costs up to $2.5 billion from tariffs [12] Group 3: Strategic Responses - To mitigate risks, automakers are diversifying and localizing supply chains, with General Motors investing in a magnet production facility in Texas and Volkswagen securing magnet supplier licenses in Europe [10]

Group 1 - Moretus Research provides high-quality equity research focused on U.S. public markets, aiming to deliver clarity, conviction, and alpha for serious investors [1] - The research framework identifies companies with durable business models, mispriced cash flow potential, and intelligent capital allocation, emphasizing a structured and repeatable approach [1] - Valuation methods are based on sector-relevant multiples tailored to each company's business model and capital structure, prioritizing comparability, simplicity, and relevance [1] Group 2 - Research coverage focuses on underappreciated companies experiencing structural changes or temporary dislocations, where disciplined analysis can yield asymmetric returns [1] - Moretus Research aims to elevate the standard for independent investment research by providing professional-grade insights and actionable valuation [1]

Core Insights - Dollar General has experienced a significant stock price increase of approximately 30% over the past three months, rising from around $85.00 to about $97.00 [1] - The company is implementing a "Back to Basics" strategy aimed at addressing past operational challenges and focusing on growth [2][11] - Analysts are increasingly optimistic about Dollar General's turnaround, with several firms raising their price targets for the stock [6][8] Strategy and Operational Improvements - The "Back to Basics" strategy includes smarter inventory management, enhancing the shopping experience through store remodels, and controlling shrinkage to protect profitability [3][4] - Dollar General aims to increase operating margins to 6-7% by 2028 or 2029, up from 4.2% reported in Fiscal 2024 [5] - The company plans to expand its fresh food offerings and open 575 new stores in the U.S. and up to 15 in Mexico in Fiscal 2025 [7] Financial Outlook - The current price-to-earnings (P/E) ratio is around 16, with a forward P/E of about 17, indicating potential value for investors if the turnaround is successful [9] - UBS Group and other analysts have raised their price targets for Dollar General, reflecting growing confidence in the company's future performance [8] Upcoming Events - The first-quarter Fiscal 2026 earnings report, expected around June 3, 2025, will be crucial in validating the turnaround narrative and building investor confidence [10][16]

Group 1 - Auxly Cannabis Group Inc. will hold its Annual General Meeting of Shareholders on June 30, 2025, at 10:00 a.m. EST in Toronto [1] - Shareholders wishing to attend in person must pre-register with the Company at least 48 hours in advance, and early registration is encouraged [2] - An audio teleconference will be available for shareholders to listen to the Meeting in real time, but they will not be able to vote or participate via teleconference [4] Group 2 - Auxly Cannabis Group Inc. is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto [5] - The Company's mission is to help consumers live happier lives through quality cannabis products that they trust and love [5] - Auxly aims to be a leader in branded cannabis products, focusing on quality, safety, and efficacy [5]

Core Viewpoint - Dollar General's stock has experienced significant volatility, with a 45% drop in 2023 and a further 44% decline in 2024, but has shown a recovery with a 31% increase year-to-date in 2025, making it one of the best performers in the S&P 500 [1] Financial Performance - Dollar General's earnings per share (EPS) have seen a sharp decline, with a 53% drop year-over-year in Q4 and a 32% decline for the full fiscal year [4][5] - The company reported diluted EPS of $5.11 for fiscal 2024, down from $10.68 in fiscal 2022, but management expects EPS to stabilize in fiscal 2025 with a forecast of $5.10 to $5.80, indicating potential growth of nearly 14% in a best-case scenario [13] Inventory Issues - A significant factor in the decline of profits has been the excessive inventory levels, which led to increased theft, damage to merchandise, and the need for discounts to clear stock [7][9] - Management has been addressing inventory issues, with theft decreasing and inventory levels approaching expected trends [10] Store Closures and One-Time Expenses - The sharp decline in Q4 profits was partly due to one-time expenses associated with closing underperforming stores, which would have otherwise resulted in relatively stable profits year-over-year [11] Economic Context - Despite high sales figures, the shift towards lower-margin food products due to economic pressures may limit profit potential [14] - Operational improvements are expected to enhance profits in the coming years, with additional growth anticipated once the economy improves [15] Valuation and Investment Potential - Dollar General's stock is currently trading at its lowest price-to-sales (P/S) valuation ever, suggesting it is undervalued relative to its profit potential [15] - If management can maintain control over past issues, the stock presents a buying opportunity as it is positioned for steady improvements [17]